Programme details

Important information

Please be aware that all times displayed on the website are set to local Paris time (CEST).

This program is subject to change without notice to attendees. The definitive version will be available soon.

Friday, June 18 2021 Saturday, June 19 2021
TV studio 1 / First series: general sessions TV studio 2 / Second series: focused topics
08:30
 - 
08:35

Introduction

Christophe BAUDOUIN.

Welcome

Christophe BAUDOUIN
08:40
 - 
09:00

Keynote lecture: Science of Tearing

Kazuo TSUBOTA.

Science of Tearing

Kazuo TSUBOTA
09:00
 - 
10:00

New concepts in DED

Christophe BAUDOUIN.

The central role of inflammation

Christophe BAUDOUIN

The central role of corneal nerves

Marc LABETOULLE

The role of hyperosmolarity

Maurizio ROLANDO

Biomarkers: what for?

Elisabeth MESSMER

Discussion

10:15
 - 
11:40

New technologies for DED diagnosis

Jose BENITEZ DEL CASTILLO.

MMP-9 immunoassay

Elisabeth MESSMER

Swiss army knife: Keratograph 5

Pedro ARRIOLA

Swiss army knife: Lacrydiag

Sihem LAZREG

Confocal Microscopy

Antoine LABBÉ

Fluorescein breakup patterns for tear film oriented diagnosis for dry eye

Norihiko YOKOI

Tear film interferometry and blinking

Jason NICHOLS

Discussion

11:45
 - 
12:30

Symposium THEA: When Dry Eye patients are unsatisfied, what do you do?

Christophe BAUDOUIN.

What causes pain in dry eye?

Christophe BAUDOUIN

Dry Eye can affect more than the eye: impact on QoL

Elisabeth MESSMER

When your patients aren't happy

Christina GRUPCHEVA

How to relieve dry eyes in clinical practice: 1rst clinical case presentation

Maurizio ROLANDO

How to relieve dry eyes in clinical practice: 2nd clinical case presentation

Renata IVEKOVIC

Discussion

13:30
 - 
14:15

Symposium ALLERGAN: Dry Eye Disease: new concepts and challenges of osmolarity

Christophe BAUDOUIN.

New concepts in Dry Eyes

Christophe BAUDOUIN

Osmoprotection, what does it mean exactly?

Marc LABETOULLE

Osmokinetics: the osmotic challenge of the Ocular Surface

Gysbert B. VAN SETTEN

Discussion

14:15
 - 
14:45

Keynote Lecture: Ménage à trois: sex, androgens and dry eye disease

David SULLIVAN.

Ménage à trois: sex, androgens and dry eye disease

David SULLIVAN
14:45
 - 
16:15

TFOS session "What a nerve"

Christophe BAUDOUIN, David SULLIVAN.

Introduction

Amy GALLANT-SULLIVAN

TFOS sactions and history

David SULLIVAN

What is neuropathic pain, and what are the underlying mechanisms?

Anat GALOR

Pain and neuroimmune cell interactions

Marzia MALCANGIO

Management of neuropathic pain

Pedram HAMRAH

Corneal nerves and Neurotrophic Keratopathy

Harminder DUA

Discussion

16:30
 - 
18:15

Iatrogenic Dry eye Joint meeting with EuCornea

Béatrice COCHENER, Elisabeth MESSMER.

Acute corneal toxicity with cancer drugs

Marc LABETOULLE

Dry Eye after stem cell transplantation

Philip STEVEN

Dry Eye in Glaucoma

Christophe BAUDOUIN

Dry Eye and Cataract Surgery

Béatrice COCHENER

Dry Eye and corneal refractive surgery

Jesus MERAYO

Dry Eye and Cosmetics / cosmetic procedures

Jutta HORVATH-WINTER

Discussion

08:30
 - 
08:35

Introduction

Christophe BAUDOUIN.

Welcome

Christophe BAUDOUIN
08:40
 - 
09:00

Keynote lecture: Science of Tearing

Kazuo TSUBOTA.

Science of Tearing

Kazuo TSUBOTA
09:00
 - 
10:00

MGD from pathophysiology to new therapeutic approaches

Kostas BOBORIDIS.

Pathophysiology of MGD

Chryssa TERZIDOU

Rosacea a major cause of MGD

Jesus MERAYO

Demodex and MGD: pathophysiology and management

Teifi JAMES

Lipid tears vs mucin-like substitutes for MGD

Antoine ROUSSEAU

Discussion

10:15
 - 
11:40

Osmolarity vs Osmokinetics: Dry Eye Static or Dynamic

Gysbert B. VAN SETTEN.

Introduction

Gysbert B. VAN SETTEN

Biophysics of cell and cell membrane

Erdinc SEZGIN

Evaporation and Osmolarity - Clinical relevance

Maurizio ROLANDO

Measuring Osmolarity

Kostas BOBORIDIS

Osmokinetics: Essential considerations and clinical releva

Gysbert B. VAN SETTEN

Osmotic Stress and Osmoprotection: Strategies and limitations

Marc LABETOULLE
11:45
 - 
12:30

Symposium THEA: When Dry Eye patients are unsatisfied, what do you do?

Christophe BAUDOUIN.

What causes pain in dry eye?

Christophe BAUDOUIN

Dry Eye can affect more than the eye: impact on QoL

Elisabeth MESSMER

When your patients aren't happy

Christina GRUPCHEVA

How to relieve dry eyes in clinical practice: 1rst clinical case presentation

Maurizio ROLANDO

How to relieve dry eyes in clinical practice: 2nd clinical case presentation

Renata IVEKOVIC

Discussion

13:30
 - 
14:15

Symposium ALLERGAN: Dry Eye Disease: new concepts and challenges of osmolarity

Christophe BAUDOUIN.

New concepts in Dry Eyes

Christophe BAUDOUIN

Osmoprotection, what does it mean exactly?

Marc LABETOULLE

Osmokinetics: the osmotic challenge of the Ocular Surface

Gysbert B. VAN SETTEN

Discussion

14:15
 - 
14:45

Keynote Lecture: Ménage à trois: sex, androgens and dry eye disease

David SULLIVAN.

Ménage à trois: sex, androgens and dry eye disease

David SULLIVAN
14:45
 - 
16:15

MGD: new devices and technologies

Gerd GEERLING.

Automated thermal pulsation treatment of MGD 1

Gerd GEERLING

IPL for dermatological disorders - How (good) does it work?

Gerd KAUTZ

IPL – The ophthalmological evidence

Elisabeth MESSMER

Microdebridement and other ways to „torture“ the lid margin

Kostas BOBORIDIS

JettPlasma treatment of MGD – What is that?

Carlos RUIZ LAPUENTE

Discussion

16:30
 - 
18:00

Contact lens/ECLSO

Francisco FIGUEIREDO, Omür UCAKHAN.

Contact Lens Discomfort and Contact Lens-Related Dry Eye

Omür UCAKHAN

Therapeutic soft Contact Lenses

Andrena MCELVANNEY

Scleral lenses

Carina KOPPEN

Contact lens related microbial keratitis

Parwez HOSSEIN

Discussion

TV studio 1 / First series: general sessions TV studio 2 / Second series: focused topics
08:30
 - 
08:55

Keynote Lecture: Inflammation in DED, from basic science to clinical developments

Michael E. STERN.

Keynote lecture: Inflammation in DED, from basic science to clinical developments

Michael E. STERN
09:00
 - 
10:00

Microbiome, a new promising concept

Pasquale ARAGONA.

The microbiome/microbiota effect on human health

Maria RESCIGNO

How the microbiota attaches to the ocular surface

Jesus MERAYO

The biofilm

Jose BENITEZ DEL CASTILLO

The ocular surface tolerance mechanisms towards the microbiota

Pasquale ARAGONA

Dry eye and the gut microbiota

Marc LABETOULLE

Discussion

10:15
 - 
11:30

Neuropathic pain: when the doctor does not understand patient’s complaints

Jesus MERAYO.

Current concepts on neuropathic pain

Jesus MERAYO

Molecular and cellular basis of neuropathic pain and integrative mechanism

Carlos BELMONTE

Diagnosis and Measurement of Neuropathic pain

Pedram HAMRAH

Management of Neuropathic pain

Jesus MERAYO

Discussion

11:45
 - 
12:30

Symposium ALCON: 20/20 unhappy after cataract surgery: an ocular surface problem ?

Christophe BAUDOUIN.

Advanced IOL optics: Keys for success

Béatrice COCHENER

Preoperative detection and management

Marc LABETOULLE

Postoperative management

Elisabeth MESSMER

Discussion

13:30
 - 
14:15

Symposium SANTEN: State-of-the-art management of dry eye disease

Christophe BAUDOUIN.

Introduction

Christophe BAUDOUIN

From lid margin disease to DED: a focus on meibomian gland dysfunction and blepharitis

Margarita CALONGE

Focussing on inflammation for the management of DED

Christophe BAUDOUIN

Evidence-based approach for the management of ocular surface inflammation in disease

Elisabeth MESSMER

Discussion & Closing remarks

Christophe BAUDOUIN
14:30
 - 
15:40

Tackling DED: toward new strategies

Stefano BARABINO, Maurizio ROLANDO.

Introduction

Maurizio ROLANDO

Controlling the shift from parainflammation to inflammation: a new perspective in DED

Stefano BARABINO

Non pharmaceutical approaches, which is their place

Jose BENITEZ DEL CASTILLO

Treatment of Pain, a look to the future

Anat GALOR

Discussion

Christophe BAUDOUIN
Elisabeth MESSMER
15:45
 - 
17:15

IT-DED3, A European Consortium for innovation

Philip STEVEN.

Opening remarks

Philip STEVEN

Introduction to the IT-DED³ Consortium

Koen AUGUSTYNS

Dry eye drug development: from the lab to the upscaling

Alba RAMOS-LLORCA

Use of natural compounds for treatment of DED and strategies for drug delivery

Luna KRSTIĆ

Biomarkers for diagnosis of DED

Adrián GUERRERO MORENO

Artificial Intelligence in dry-eye diagnosis - academic and industrial collaboration

Asif KHAN SETU

Translational applications of basic research - Advisory Board perspective

Michael E. STERN

Discussion & Closing remarks

17:20
 - 
17:30

CONCLUDING REMARKS

Christophe BAUDOUIN.

Conclusion

Christophe BAUDOUIN
08:30
 - 
08:55

Keynote Lecture: Inflammation in DED, from basic science to clinical developments

Michael E. STERN.

Keynote lecture: Inflammation in DED, from basic science to clinical developments

Michael E. STERN
09:00
 - 
10:00

Dry eye and Allergy: close relationships

Stefano BONINI, Andrea LEONARDI.

Dry Eye and Ocular Allergy: common features

Edoardo VILLANI

Allergic and non allergic blepharitis: How to make the difference?

Serge DOAN

Common and different pathways

Andrea LEONARDI

Common and different therapeutic approaches

Stefano BONINI

Discussion

10:15
 - 
11:30

Vision and DE

Murat IRKEC.

Impact of DED on QoL and vision

Antoine LABBÉ

Mechanisms of visual disturbance in DED

Murat IRKEC

Optical quality of ocular surface in normals and DED patients

Jose BENITEZ DEL CASTILLO

Management of DED-associated visual problems

Murat DOGRU

Discussion

11:45
 - 
12:30

Symposium ALCON: 20/20 unhappy after cataract surgery: an ocular surface problem ?

Christophe BAUDOUIN.

Advanced IOL optics: Keys for success

Béatrice COCHENER

Preoperative detection and management

Marc LABETOULLE

Postoperative management

Elisabeth MESSMER

Discussion

13:30
 - 
14:15

Symposium SANTEN: State-of-the-art management of dry eye disease

Christophe BAUDOUIN.

Introduction

Christophe BAUDOUIN

From lid margin disease to DED: a focus on meibomian gland dysfunction and blepharitis

Margarita CALONGE

Focussing on inflammation for the management of DED

Christophe BAUDOUIN

Evidence-based approach for the management of ocular surface inflammation in disease

Elisabeth MESSMER

Discussion & Closing remarks

Christophe BAUDOUIN
14:30
 - 
15:40

Biomarkers for Dry Eye Disease: aims and technologies

Margarita CALONGE.

Biomarkers in DED: introduction of session and invited speakers

Margarita CALONGE

Tear vs cell strategies as biomarkers for DED

Christophe BAUDOUIN

Tear molecules and -omic technologies in DED

Piera VERSURA

How tear/cell biomarkers for DED can help clinicians

Amalia ENRÍQUEZ-DE-SALAMANCA

Discussion

15:45
 - 
17:15

Young Ophthalmologists: a sense of innovation

Francesc MARCH DE RIBOT.

Ocular surface frailty index as a predictor of dry eye symptoms

Edoardo VILLANI

Digital solutions for dry eye

Luis Alfonso HERNÁNDEZ PIÑAMORA

Intense Pulsed Light new approach for dry eye

Filipe ESTEVES

Microblepharoexfoliation Procedure: New approach against eyelids biofilm

Renato PAPA

Salivary gland implant for dry eye

Jaime MARTINEZ

Dry eye in covid pandemic

Mridula AMARNATH

New times for dry eye

Francesc MARCH DE RIBOT

Discussion


Our partners